Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein

被引:21
作者
Cracowski, JL [1 ]
Stanke-Labesque, F
Sessa, C
Hunt, M
Chavanon, O
Devillier, P
Bessard, G
机构
[1] Fac Med Grenoble, PCEBM, Pharmacol Lab, F-38706 La Tronche, France
[2] CHU Grenoble, Dept Vasc Surg, Grenoble, France
[3] CHU Grenoble, Dept Cardiac Surg, Grenoble, France
关键词
femoral arteries; vascular reactivity; thromboxane A(2); endothelin-1; leukotrienes;
D O I
10.1139/cjpp-77-10-770
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human femoral, internal mammary, and gastroepiploic arteries and saphenous veins are used as bypass grafts for coronary surgery or for reconstruction in arterial occlusive disease. We have characterized the contractile responses of these vessels to various agents that are liberated during cardiac or vascular surgery. In organ baths, U46619 (a stable thromboxane A(2) mimetic), norepinephrine, endothelin-1, angiotensin II, and KCl caused concentration-dependent contractions in all vessels tested. Leukotriene C-4 did not induce any contraction in the arteries, whereas a contraction was obtained in the saphenous vein rings. U46619 induced the most powerful contraction in all vessels tested. The pD(2) values for each agent did not differ among the different vessels. When responses were expressed as a percentage of KCl-induced contraction, the contraction of endothelin-1 (151 +/- 5%) and leukotriene C-4 (43 +/- 5%) was more significant on saphenous veins than on arteries. In conclusion, thromboxane A(2) appears to be the most potent endogenous constricting agent on different human vascular beds. Our second finding is that saphenous veins are more sensitive to contract to leukotriene C-4 and endothelin-1 than arteries. These properties may influence early and (or) long-term vein graft patency.
引用
收藏
页码:770 / 776
页数:7
相关论文
共 46 条
[1]  
ADDONIZIO VP, 1980, J THORAC CARDIOV SUR, V79, P91
[2]   ENDOTHELIAL FUNCTION OF HUMAN GASTROEPIPLOIC ARTERY IN COMPARISON WITH SAPHENOUS-VEIN [J].
AKAR, F ;
UYDES, BS ;
AYRANCIOGLU, K ;
YENER, A ;
ASLAMACI, S ;
ARSAN, M ;
TORUNER, A ;
KANZIK, I .
CARDIOVASCULAR RESEARCH, 1994, 28 (04) :500-504
[3]   Differential leukotriene constrictor responses in human atherosclerotic coronary arteries [J].
Allen, S ;
Dashwood, M ;
Morrison, K ;
Yacoub, M .
CIRCULATION, 1998, 97 (24) :2406-2413
[4]   PREFERENTIAL VASOCONSTRICTION TO CYSTEINYL LEUKOTRIENES IN THE HUMAN SAPHENOUS-VEIN COMPARED WITH THE INTERNAL MAMMARY ARTERY - IMPLICATIONS FOR GRAFT PERFORMANCE [J].
ALLEN, SP ;
CHESTER, AH ;
DASHWOOD, MR ;
TADJKARIMI, S ;
PIPER, PJ ;
YACOUB, MH .
CIRCULATION, 1994, 90 (01) :515-524
[5]   ENHANCED EXCRETION OF URINARY LEUKOTRIENE-E(4) IN CORONARY-ARTERY DISEASE AND AFTER CORONARY-ARTERY BYPASS-SURGERY [J].
ALLEN, SP ;
SAMPSON, AP ;
PIPER, PJ ;
CHESTER, AH ;
OHRI, SK ;
YACOUB, MH .
CORONARY ARTERY DISEASE, 1993, 4 (10) :899-904
[6]   ENDOTHELIAL AT(1)-MEDIATED RELEASE OF NITRIC-OXIDE DECREASES ANGIOTENSIN-II CONTRACTIONS IN RAT CAROTID-ARTERY [J].
BOULANGER, CM ;
CAPUTO, L ;
LEVY, BI .
HYPERTENSION, 1995, 26 (05) :752-757
[7]  
CHARDIGNY C, 1993, CIRCULATION, V88, P115
[8]   REACTIVITY OF ENDOTHELIN-1 ON HUMAN AND CANINE LARGE VEINS COMPARED WITH LARGE ARTERIES INVITRO [J].
COCKS, TM ;
FAULKNER, NL ;
SUDHIR, K ;
ANGUS, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 171 (01) :17-24
[9]   ENDOTHELIN IS BLOOD-VESSEL SELECTIVE - STUDIES ON A VARIETY OF HUMAN AND DOG VESSELS INVITRO AND ON REGIONAL BLOOD-FLOW IN THE CONSCIOUS RABBIT [J].
COCKS, TM ;
BROUGHTON, A ;
DIB, M ;
SUDHIR, K ;
ANGUS, JA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1989, 16 (04) :243-246
[10]   COMPARISON OF THE ACTIONS OF U-46619, A PROSTAGLANDIN H2-ANALOGUE, WITH THOSE OF PROSTAGLANDIN-H2 AND THROMBOXANE-A2 ON SOME ISOLATED SMOOTH-MUSCLE PREPARATIONS [J].
COLEMAN, RA ;
HUMPHREY, PPA ;
KENNEDY, I ;
LEVY, GP ;
LUMLEY, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (03) :773-778